tetramethylrhodamine isothiocyanate has been researched along with Acute Promyelocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alayed, KM; Bueso-Ramos, CE; Konoplev, S; McCord, Y; Medeiros, LJ; Ojiaku, C; Patel, J; Phan, D; Reyes, SR; Woods, JS; Yap, JP | 1 |
1 other study(ies) available for tetramethylrhodamine isothiocyanate and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Female; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nuclear Proteins; Promyelocytic Leukemia Protein; Prospective Studies; Rhodamines; Transcription Factors; Tumor Suppressor Proteins | 2013 |